Want to see LENZ full AI Analyst Report?
LENZ Therapeutics (LENZ) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Lnz101 (Aceclidine /Brimonidine) Ophthalmic Solution, Lnz100 (Aceclidine) Ophthalmic Solution | Presbyopia | Phase I | Completed | Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia | Feb 06, 2024 | ― |
| Aceclidine+Brimonidine Combination Ophthalmic Solution, Aceclidine Ophthalmic Solution | Presbyopia, Eye Diseases, Near Vision, Miosis | Phase III | Completed | Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia | Sep 13, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Lnz101 (Aceclidine /Brimonidine) Ophthalmic Solution, Lnz100 (Aceclidine) Ophthalmic Solution | Phase I | Presbyopia | Completed | Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia | Feb 06, 2024 | ― |
| Aceclidine+Brimonidine Combination Ophthalmic Solution, Aceclidine Ophthalmic Solution | Phase III | Presbyopia, Eye Diseases, Near Vision, Miosis | Completed | Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia | Sep 13, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lenz Therapeutics, Inc. (LENZ) have in its pipeline
LENZ Therapeutics LENZ is currently developing the following drugs: Lnz101 (Aceclidine /Brimonidine) Ophthalmic Solution, Lnz100 (Aceclidine) Ophthalmic Solution, Aceclidine+Brimonidine Combination Ophthalmic Solution, Aceclidine Ophthalmic Solution. These drug candidates are in various stages of clinical development as the company works toward FDA approval.